- Visibility7
- Citations0
- Sentiment50
- Site quality67
- AI readiness21
AI assistants rarely name Revvity in their answers, mentioning the company in 1 out of 60 responses. Revvity has an overall score of 25 out of 100, ranking 1,805th of 2,047 companies measured. Its website passes 3 of 14 technical checks for readiness with AI tools.
We asked 15 unbranded questions about the healthcare market: none named Revvity. AI assistants named it in 1 of 60 answers (1.7%). The typical healthcare company is named in 3.3% of answers. By how often it is named, Revvity ranks 56 of 105 in its sector.
Named fewer than three times in total. Read this as a sign that AI assistants rarely bring this company up, not as an exact comparison with its rivals.
Every dot is a company in the study. Hover one to see it; click to open its report.
This companySame sectorEvery other companyNever named
Five parts, each scored out of 100.
How often AI assistants name the company
How often AI uses the company's own website as a source
How positively AI describes the company
How well built the website's own pages are
How easily AI tools can read and use the website
Visibility is calculated from the answers on this page. How the score is built.
105 companies in this sector. The line on each bar is the typical company.
An answer that names the company
“Which integrated health science platforms are most effective for preclinical development workflows?”
Short answer — there isn’t a single “best” product for every team. But in practice the platforms most frequently judged effective for end‑to‑end preclinical workflows are Benchling, Genedata (Biologics / Bioprocess / Biopharma), Dotmatics, Thermo Fisher SampleManager (and broader Thermo informatics), PerkinElmer / Revvity Signals, LabVantage, and Certara (for quantitative translational / PK/PD modeling). Below I summarize what each does well, when to prefer it, and how to pick between them.
What leading platforms are strong for preclinical development
Benchling — unified ELN + LIMS-style s …
The AI’s answer as we received it, shortened and not checked for accuracy.
How the mentions in these answers were split between this company and its rivals
Answers naming it, out of answers received
What this website publishes for an AI agent to read, use and buy from, on a scale of six levels.
- 0
- 1
- 2
- 3
- 4
- 5
Level 1: Basic web presence. Two of robots.txt, a sitemap and Link headers are in place.
- Content Signals
The website turns away requests that do not come from a browser. AI agents that say what they are meet the same refusal.
Show every check, for your technical teamHide the checks
- study: 92.0%robots.txtPassed
A valid robots.txt with crawl rules at the site root.
- study: 86.8%SitemapPassed
An XML sitemap listing the pages, ideally referenced from robots.txt.
- study: 0.3%Link headersNot met
Send Link headers such as rel="api-catalog" or rel="describedby" on the homepage.
- study: 5.5%DNS for AI DiscoveryNot present
Advertise agent endpoints with SVCB records under _agents.
- study: 1.9%Markdown negotiationNot met
Return a markdown version when asked with Accept: text/markdown, for example at the CDN.
- study: 25.1%llms.txtPassed
An llms.txt that tells language models what the site offers.
- study: 93.4%AI bot rulesPassed
Explicit robots.txt rules for AI crawlers such as GPTBot, ClaudeBot and PerplexityBot.
- study: 1.4%Content SignalsNot met
Add a Content-Signal line for search, ai-input and ai-train to robots.txt.
- study: 0.2%Web Bot AuthNot present
Only relevant if you run your own agents or crawlers: publish a signing key directory.
- study: 0.3%API CatalogNot met
List public APIs in a linkset at /.well-known/api-catalog.
- study: 11.8%OAuth discoveryNot met
Publish OpenID Connect or OAuth server metadata under /.well-known.
- study: 10.3%OAuth Protected ResourceNot met
Serve protected resource metadata at /.well-known/oauth-protected-resource.
- study: 0.0%auth.mdNot met
Publish an auth.md describing how agents sign in.
- study: 0.2%MCP Server CardNot met
Offer an MCP server and publish its server card under /.well-known.
- study: 0.1%A2A Agent CardNot met
Publish an agent card at /.well-known/agent-card.json.
- study: 0.2%Agent SkillsNot met
Publish a skills index with the main tasks agents can do.
- study: 33.7%WebMCPCould not check
Register key actions such as search or cart as WebMCP tools.
- study: 0.1%ARD manifestNot met
Publish an ai-catalog.json listing every agent interface.
Score 43 of 100 · 97% of checks could run · checked on October 4, 2026 · revvity.com · 2,047 companies scanned
3 of 14 passed. This list is for your technical team. The percentage is how many companies in the study pass each check.
These 14 checks ran during the audit and are what the AI readiness part of the overall score counts. The scan above ran later and is stricter on Link headers and Markdown, so a check can pass here and not there.
Show the 14 checksHide them
- Not metrobots.txt publishedstudy: 85.0%
- Not metXML sitemapstudy: 73.2%
- PassedHTTP Link headers (RFC 8288)study: 29.0%
- Not metMarkdown content negotiationstudy: 8.3%
- Passedllms.txt publishedstudy: 21.7%
- Not metToken budget (page weight)study: 95.2%
- PassedExplicit AI bot rulesstudy: 13.0%
- Not metAPI Catalog (.well-known/api-catalog)study: 0.2%
- Not metOAuth Authorization Server discoverystudy: 10.1%
- Not metOAuth Protected Resource discoverystudy: 9.3%
- Not metMCP Server Cardstudy: 0.0%
- Not metA2A Agent Cardstudy: 0.0%
- Not metWebMCP toolsstudy: 4.2%
- Not metAgent Skills declaredstudy: 0.0%
How many times each website was listed as a source in these answers
In the study as S&P 500.
- Which integrated health science platforms are most effective for preclinical development workflows?
- How can connected lab automation speed up target identification in pharmaceutical research?
- How to address data integration issues between different informatics tools in drug discovery pipelines
- Alternatives to end-to-end AI workflow solutions for research teams with limited budgets
- Estimated costs for implementing integrated automation and informatics systems in biopharmaceutical labs
- Common challenges when implementing AI-driven workflow automation in biological data analysis
- Options for supplementing manual laboratory processes without full automation investment
- What are the best AI-powered workflow solutions for streamlining drug discovery in the US?
- How do automated laboratory informatics systems compare to traditional manual workflows in life sciences research?
- Is investing in an end-to-end AI-powered health science solution worth it for mid-sized research teams?
- What factors influence the pricing of AI-powered scientific workflow solutions in the United States?
- Top bioinformatics features to look for in AI-driven platforms for health science research
- Lab-in-the-loop AI platforms vs standard laboratory automation: what are the key differences for drug development?
- What should researchers consider before purchasing integrated platforms for clinical development?
- Practical applications of AI-powered imaging technologies for life science laboratories
Columns, left to right: OpenAI, Claude, Perplexity, Gemini. The AI assistants often disagree. Across the study, on 40% of the questions where a company is named, only one of the four names it.